MedTrace Logo

Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction

NCT05242107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-02-16

No results posted yet for this study

Summary

The aim of our study will demonstrate the effect of omega 3 supplementation on serum lipid profile level and leptin level in neonates with Intrauterine Growth Restriction( IUGR)

Conditions

  • Lipid Profile
  • Neonates
  • Intrauterine Growth Restriction

Interventions

DIETARY_SUPPLEMENT

Omega-3 supplement group

35 Neonates were given Omega 3 in a dose of 40mg/kg/day (8), after establishment of full-feeding and for 2 weeks duration. Omega-300 (Montana pharmaceutical industry) capsule was used which contains 1000mg Omega 3 fatty acids.

OTHER

Full feeding without receiving any supplementation group

35 full term Growth Restriction( IUGR) neonates who were followed up to full feeding without receiving any supplementation.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
4 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-01-01
Completion
2022-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05242107 on ClinicalTrials.gov